http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180105462-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5f41889212134f724ee94357d02f4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f157fcc4fe1dfe990bc009126cb56122 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4997ee626d3b308621cd7f8d763b6552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51d9962e45916c70712b3faf4f167a16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe2cb2be979fb6311cfd430e7396646e |
| publicationDate | 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180105462-A |
| titleOfInvention | Composition for diagnosing lung cancer, assaying drug response and prognosis through analysis of extracellular vesicle isolated from blood |
| abstract | The present invention relates to a composition for diagnosis or prognosis prediction of lung cancer that analyzes extracellular endoplasmic reticulum isolated from the blood of a patient suffering from lung cancer, a kit for predicting lung cancer diagnosis or prognosis comprising the composition, and information for predicting lung cancer diagnosis or prognosis using the composition ≪ / RTI > The method of detecting mutation of lung cancer expressing gene using blood according to the present invention is noninvasive, easy, repeatable, and highly sensitive than gene mutation detection through histological examination. It is easy to detect cancer-causing mutation induced by anticancer drugs. In addition, the blood of patients with lung cancer is comparatively easy to obtain. Using the blood-derived extracellular endoplasmic reticulum, various information of DNA, RNA, protein, lipid, and sugar biomolecules derived from cancer cells can be analyzed, Therefore, early detection of lung cancer or measurement of prognosis can contribute to enhancement of lung cancer treatment efficiency. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220150236-A |
| priorityDate | 2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 124.